{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,13]],"date-time":"2026-04-13T12:20:24Z","timestamp":1776082824161,"version":"3.50.1"},"reference-count":25,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"DOI":"10.1210\/jc.2008-1241","type":"journal-article","created":{"date-parts":[[2008,8,6]],"date-time":"2008-08-06T18:43:12Z","timestamp":1218048192000},"page":"2972-2974","source":"Crossref","is-referenced-by-count":33,"title":["A New Form of Hereditary Primary Aldosteronism: Familial Hyperaldosteronism Type III"],"prefix":"10.1210","volume":"93","author":[{"given":"Paolo","family":"Mulatero","sequence":"first","affiliation":[{"name":"Department of Medicine and Experimental Oncology, Division of Internal Medicine 4 and Hypertension, University of Torino, 10126 Torino, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"80","reference":[{"key":"2020071613302505500_R1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.tem.2005.02.007","article-title":"Diagnosis of primary aldosteronism: from screening to subtype differentiation.","volume":"16","author":"Mulatero","year":"2005","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613302505500_R2","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1210\/en.2003-0279","article-title":"Minireview. Primary aldosteronism: changing concepts in diagnosis and treatment.","volume":"144","author":"Young Jr","year":"2003","journal-title":"Endocrinology"},{"key":"2020071613302505500_R3","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jc.2003-031337","article-title":"Increased diagnosis of primary aldosteronism, including surgically correctable forms, in centers from five continents.","volume":"89","author":"Mulatero","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R4","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism.","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"2020071613302505500_R5","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1365-2265.2007.02898.x","article-title":"Diagnosis and treatment of low-renin hypertension.","volume":"67","author":"Mulatero","year":"2007","journal-title":"Clin Endocrinol"},{"key":"2020071613302505500_R6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/S1043-2760(03)00112-7","article-title":"Primary aldosteronism: from genesis to genetics.","volume":"14","author":"Stowasser","year":"2003","journal-title":"Trends Endocrinol Metab"},{"key":"2020071613302505500_R7","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1097\/00004872-200404000-00001","article-title":"Genetics of primary aldosteronism.","volume":"22","author":"Mulatero","year":"2004","journal-title":"J Hypertens"},{"key":"2020071613302505500_R8","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human Mendelian hypertension featuring non-glucocorticoid remediable aldosteronism","volume":"93","author":"Geller","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R9","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1038\/ng0992-66","article-title":"Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase.","volume":"2","author":"Lifton","year":"1992","journal-title":"Nat Genet"},{"key":"2020071613302505500_R10","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1210\/jcem.87.7.8647","article-title":"Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree.","volume":"87","author":"Mulatero","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R11","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/sj.jhh.1001636","article-title":"Coexistence of different phenotypes in a family with glucocorticoid-remediable aldosteronism.","volume":"18","author":"Fallo","year":"2004","journal-title":"J Hum Hypertens"},{"key":"2020071613302505500_R12","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1097\/HJH.0b013e3283028352","article-title":"Further evidence for linkage of familial hyperaldosteronism type II at chromosome 7p22 in Italian as well as Australian and South American families.","volume":"26","author":"Sukor","year":"2008","journal-title":"J Hypertens"},{"key":"2020071613302505500_R13","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22).","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"2020071613302505500_R14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa033263","article-title":"Serum aldosterone and the incidence of hypertension in nonhypertensive persons.","volume":"351","author":"Vasan","year":"2004","journal-title":"N Engl J Med"},{"key":"2020071613302505500_R15","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1161\/01.HYP.0000258554.87444.91","article-title":"Clinical and genetic correlates of aldosterone-to-renin ratio and relations to blood pressure in a community sample.","volume":"49","author":"Newton-Cheh","year":"2007","journal-title":"Hypertension"},{"key":"2020071613302505500_R16","doi-asserted-by":"crossref","first-page":"2573","DOI":"10.1210\/jcem.83.7.4946","article-title":"Diagnosis of glucocorticoid-remediable aldosteronism in primary aldosteronism: aldosterone response to dexamethasone and long polymerase chain reaction for chimeric gene.","volume":"83","author":"Mulatero","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R17","doi-asserted-by":"crossref","first-page":"4805","DOI":"10.1210\/jcem.86.10.7920","article-title":"Genetic study of patients with dexamethasone-suppressible aldosteronism without the chimeric CYP11B1\/CYP11B2 gene.","volume":"86","author":"Fardella","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R18","first-page":"1863","article-title":"Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.","volume":"85","author":"Fardella","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/sj.emboj.7601934","article-title":"Invalidation of TASK1 potassium channels disrupts adrenal gland zonation and mineralocorticoid homeostasis.","volume":"27","author":"Heitzmann","year":"2008","journal-title":"EMBO J"},{"key":"2020071613302505500_R20","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2265.2001.01192.x","article-title":"A chimeric CYP11B1\/CYP11B2 gene in glucocorticoid-insuppressible familial hyperaldosteronism.","volume":"55","author":"Ise","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071613302505500_R21","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1210\/jcem.86.9.7903","article-title":"Clinical and molecular features of the Carney complex: diagnostic criteria and recommendations for patient evaluation.","volume":"86","author":"Stratakis","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R22","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/s00467-003-1339-2","article-title":"Non-glucocorticoid-remediable aldosteronism in an infant with low-renin hypertension.","volume":"19","author":"Malagon-Rogers","year":"2004","journal-title":"Pediatr Nephrol"},{"key":"2020071613302505500_R23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1210\/jcem-55-5-1013","article-title":"Familial hyperaldosteronism, not suppressed by dexamethasone.","volume":"55","author":"Greco","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071613302505500_R24","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0092-8674(01)00241-0","article-title":"Molecular mechanisms of human hypertension.","volume":"104","author":"Lifton","year":"2001","journal-title":"Cell"},{"key":"2020071613302505500_R25","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1097\/01.hjh.0000174299.66369.26","article-title":"Familial hyperaldosteronism type II is linked to the chromosome 7p22 region but also shows predicted heterogeneity.","volume":"23","author":"So","year":"2005","journal-title":"J Hypertens"}],"container-title":["The Journal of Clinical Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/8\/2972\/9052546\/jcem2972.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/93\/8\/2972\/9052546\/jcem2972.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,16]],"date-time":"2020-07-16T23:59:21Z","timestamp":1594943961000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/93\/8\/2972\/2598410"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jc.2008-1241","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8,1]]}}}